M&A Deal Summary |
|
---|---|
Date | 2024-04-02 |
Target | Appili Therapeutics |
Sector | Life Science |
Buyer(s) | Aditxt |
Deal Type | Add-on Acquisition |
Advisor(s) | Dentons (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2017 |
Sector | Life Science |
Employees | 47 |
Revenue | 1M USD (2023) |
Aditxt is developing technologies focused on improving the immune system's health through immune monitoring and reprogramming. Aditxt was founded in 2017 and is based in Richmond, Virginia.
DEAL STATS | # |
---|---|
Overall | 4 of 4 |
Sector (Life Science) | 4 of 4 |
Type (Add-on Acquisition) | 3 of 3 |
State (Nova Scotia) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2024) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-01-30 |
Brain Scientific - portfolio of EEG brain monitoring technologies and devices
United States Brain Scientific's portfolio of EEG brain monitoring technologies and devices includes 16 patents, with the flagship products being a disposable NeuroCap and portable NeuroEEG, intended to enable neurologists to streamline their processes by enhancing throughput, increasing patient comfort, and mitigating contamination risks. |
Buy | - |